Skip to content
AnalystLens

Cigna Group 8-K Report, Financial Results (Oct 31, 2024)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed October 31, 2024
Period End
October 31, 2024
Security
CI
In the record · 2018–202610-K810-Q238-K136

CI filed 8 annual reports (10-K), 23 quarterly reports (10-Q) and 136 current reports (8-K) between 2018 and 2026.

  1. Deal closed8-K · Feb ’19Feb ’19
  2. Material agreement8-K · Apr ’21Apr ’21
  3. Leadership change8-K · Sep ’23Sep ’23
  4. Leadership change8-K · Oct ’26Oct ’26

01—Abstract

Summary

Summary of the 8-K filed October 31, 2024. Cited figures are marked; the original filing is the authoritative source.

The Cigna Group (CI) reported third quarter 2024 results on October 31, 2024, showing strong top-line growth and a reaffirmed full-year adjusted EPS outlook.

Total revenues rose 30% year over year to $63.7 billiona, driven mainly by Evernorth Health Services, which benefited from large client wins and strong specialty volume growth. Shareholders' net income was $0.7 billion, or $2.63 per share, but this figure absorbed a non-cash after-tax $1.0 billion ($3.69 per share) investment loss tied to VillageMD. Adjusted income from operations was $2.1 billion, or $7.51 per share, up from $6.77 a year earlier.

Profitability was mixed beneath the headline. Evernorth's pre-tax adjusted income grew 9%b, and Specialty and Care Services was a clear bright spot with 23% growth, while Pharmacy Benefit Services grew only 3% on a 50% revenue increase, reflecting thinner margins from client wins and planned investments. Cigna Healthcare's pre-tax adjusted income fell 4%, as the medical care ratio rose to 82.8% from 80.5%, partly due to business mix and an extra business day.

The SG&A expense ratio improved sharply to 5.6%c from 7.7%, indicating operating efficiency gains. Total medical customers declined to 19.0 million, mainly from Individual and Family Plans attrition tied to targeted pricing actions, while pharmacy customers grew 22% year to date.

Management reaffirmed full-year 2024 adjusted income from operations of at least $28.40d per share, with Evernorth pre-tax adjusted income of at least $7.0 billion, Cigna Healthcare pre-tax adjusted income of at least $4.775 billion, and a Cigna Healthcare MCR guided to 81.7%–82.5%. Investors should note that the outlook excludes future realized investment results and special items, which can materially affect GAAP earnings, and that the VillageMD impairment illustrates the risk in the company's provider-model investments.

02—Key points

Key Highlights

  1. Total revenues up 30% year over year to $63.7 billion, led by Evernorth Health Services client wins and specialty volume growth.
  2. GAAP shareholders' net income of $2.63 per share, depressed by a $3.69 per share after-tax non-cash VillageMD investment loss; adjusted EPS was $7.51 versus $6.77 a year earlier.
  3. Specialty and Care Services adjusted pre-tax income rose 23%, while Pharmacy Benefit Services grew only 3% despite 50% revenue growth.
  4. Cigna Healthcare MCR rose to 82.8% from 80.5%, pressuring segment pre-tax adjusted income, which fell 4%.
  5. SG&A expense ratio improved to 5.6% from 7.7%, reflecting business mix, revenue scale, and operating efficiency.
  6. 2024 adjusted EPS outlook of at least $28.40 reaffirmed, with Evernorth pre-tax income guided to at least $7.0 billion and Cigna Healthcare to at least $4.775 billion.
  7. Medical customers declined to 19.0 million on Individual and Family Plans attrition from targeted pricing, while total customer relationships reached 183.5 million.

03—Questions

Frequently Asked Questions

  1. Why did GAAP earnings fall so much compared with adjusted earnings?

    Shareholders' net income of $2.63 per share included a non-cash after-tax $1.0 billion ($3.69 per share) loss related to VillageMD, along with realized investment losses and amortization of acquired intangibles. Management excludes these items from adjusted income from operations, which was $7.51 per share.

  2. Is the 2024 earnings outlook changing?

    No. The Cigna Group reaffirmed its full-year 2024 adjusted income from operations outlook of at least $28.40 per share. The outlook excludes future realized investment results and special items, which can vary materially and affect GAAP results.

  3. What is driving the revenue growth, and is it translating into profit?

    Revenue growth is driven by large client wins and strong specialty volume in Evernorth. Profit growth is more modest: Evernorth pre-tax adjusted income rose 9%, with Specialty and Care Services up 23% but Pharmacy Benefit Services up only 3%, as lower-margin growth and planned investments weighed on results.

  4. Why did Cigna Healthcare earnings decline?

    Cigna Healthcare pre-tax adjusted income fell 4% year over year, mainly because its medical care ratio rose to 82.8% from 80.5%. Management cited business mix, one extra business day, and lower net investment income, partly offset by operating efficiency. Premium rate increases were intended to cover higher underlying medical costs.

  5. Are membership trends a concern for investors?

    Medical customers fell to 19.0 million, reflecting a year-to-date decline in Individual and Family Plans driven by targeted pricing actions. Pharmacy customers grew 22% year to date to 120.0 million, and total customer relationships rose 12% to 183.5 million, so the mix is shifting toward pharmacy and specialty services.

04—Continue

← View all 8-K filings